The validity of self-reported use of hormone replacement therapy among Danish nurses

Acta Obstetricia et Gynecologica Scandinavica

Volumn 83, Issue 5, 2004, Pages 476-481

  Løkkegaard, Ellen Leth ^a,e   Johnsen, Søren Påske ^b   Heitmann, Berit Lillienthal ^c   Stahlberg, Claudia ^d   Pedersen, Anette Tønnes ^d   Obel, Erik Bernhard ^e   Hundrup, Yrsa Andersen ^e   Hallas, Jesper ^f   Sørensen, Henrik Toft ^b  

^a HVIDOVRE HOSPITAL   (Denmark)

^b AALBORG UNIVERSITY   (Denmark)

^c The Capital Region   (Denmark)

^d Rigshospitalet   (Denmark)

^e UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^f UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Epidemiology; Hormone replacement therapy; Questionnaire; Self reports; Sensitivity; Specificity; Validity

Indexed keywords

ALCOHOL; ESTROGEN; GESTAGEN; HORMONE;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; ETHNIC GROUP; FEMALE; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; LIFESTYLE; MAJOR CLINICAL STUDY; NATIONAL HEALTH SERVICE; NURSE; PHYSICAL ACTIVITY; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE; REGISTER; REIMBURSEMENT; SELF REPORT; SENSITIVITY AND SPECIFICITY; SMOKING; VALIDATION PROCESS;

AGED; COHORT STUDIES; DENMARK; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MIDDLE AGED; NURSES; POSTMENOPAUSE; QUESTIONNAIRES; SELF ASSESSMENT (PSYCHOLOGY); SENSITIVITY AND SPECIFICITY;

EID: 2042472151     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0001-6349.2004.00376.x     Document Type: Article

References (22)

1. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. J Am Med Assoc 1998; 280: 605-13.
2. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative randomized controlled trial. J Am Med Assoc 2002; 288: 321-33.
3. Waters DD, Alderman EL, Hsia J, Howard BV, Cobb FR, Rogers WJ et al. Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial. J Am Med Assoc 2002; 288: 2432-40.
4. Grady D, Rubin SM, Petitti DB, Fox CS, Black D, Ettinger B et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992; 117: 1016-37.
5. Nelson HD, Humphrey LL, Nygren P, Teutsch SM, Allan JD. Postmenopausal hormone replacement therapy: scientific review. J Am Med Assoc 2002; 288: 872-81.
6. Matthews KA, Kuller LH, Wing RR, Meilahn EN, Plantinga P. Prior to use of estrogen replacement therapy, are users healthier than nonusers? Am J Epidemiol 1996; 143: 971-8.
7. Rodstrom K, Bengtsson C, Lissner L, Bjorkelund C. Pre-existing risk factor profiles in users and non-users of hormone replacement therapy: prospective cohort study in Gothenburg, Sweden. Br Med J 1999; 319: 890-3.
8. Greendale GA, James MK, Espeland MA, Barrett-Connor E. Can we measure prior postmenopausal estrogen/progestin use? The Postmenopausal Estrogen/Progestin Interventions Trial. The PEPI Investigators. Am J Epidemiol 1997; 146: 763-70.
9. Merlo J, Berglund G, Wirfalt E, Gullberg B, Hedblad B, Manjer J et al. Self-administered questionnaire compared with a personal diary for assessment of current use of hormone therapy: an analysis of 16,060 women. Am J Epidemiol 2000; 152: 788-92.
10. Horwitz RI, Yu EC. Problems and proposals for interview data in epidemiological research. Int J Epidemiol 1985; 14: 463-7.
11. Lipworth L, Fryzek JP, Fored CM, Blot WJ, McLaughlin JK. Comparison of surrogate with self-respondents regarding medical history and prior medication use. Int J Epidemiol 2001; 30: 303-8.
12. Banks E, Beral V, Cameron R, Hogg A, Langley N, Barnes I et al. Agreement between general practice prescription data and self-reported use of hormone replacement therapy and treatment for various illnesses. J Epidemiol Biostat 2001; 6: 357-63.
13. Jain MG, Rohan TE, Howe GR. Agreement of self-reported use of menopausal hormone replacement therapy with physician reports. Epidemiology 1999; 10: 260-3.
14. Goodman MT, Nomura AM, Wilkens LR, Kolonel LN. Agreement between interview information and physician records on history of menopausal estrogen use. Am J Epidemiol 1990; 131: 815-25.
15. Linet MS, Harlow SD, McLaughlin JK, McCaffrey LD. A comparison of interview data and medical records for previous medical conditions and surgery. J Clin Epidemiol 1989; 42: 1207-13.
16. Paganini-Hill A, Ross RK. Reliability of recall of drug usage and other health-related information. Am J Epidemiol 1982; 116: 114-22.
17. West SL, Savitz DA, Koch G, Strom BL, Guess HA, Hartzema A. Recall accuracy for prescription medications: self-report compared with database information. Am J Epidemiol 1995; 142: 1103-12.
18. Persson I, Bergkvist L, Adami HO. Reliability of women's histories of climacteric oestrogen treatment assessed by prescription forms. Int J Epidemiol 1987; 16: 222-8.
19. West SL, Savitz DA, Koch G, Sheff KL, Strom BL, Guess HA et al. Demographics, health behaviors, and past drug use as predictors of recall accuracy for previous prescription medication use. J Clin Epidemiol 1997; 50: 975-80.
20. Hundrup YA, Obel EB, Rasmussen NK, Philip J. Use of hormone replacement therapy among Danish nurses in 1993. Acta Obstet Gynecol Scand 2000; 79: 194-201.
21. Gaist D, Sorensen HT, Hallas J. The Danish prescription registries. Dan Med Bull 1997; 44: 445-8.
22. Olsen JH, Sorensen HT, Friis S, McLaughlin JK, Steffensen FH, Nielsen GL et al. Cancer risk in users of calcium channel blockers. Hypertension 1997; 29: 1091-4.